To a suspension of hydrazine 8 (875 mg, 3.72 mmol) in EtOH (12 mL) was added 2-methylbenzaldehyde (447 mg, 3.72 mmol). The mixture was heated to reflux for 2 h, then cooled to room temperature. The resulting solid was filtered and washed with EtOH to give the hydrazone 9. To a suspension of the crude hydrazone 9 in anhydrous CH2Cl2/MeOH (10:2, 19 mL) was added (diacetoxyiodo)benzene (1.68 g, 5.21 mmol) at 0°C. The mixture was stirred at room temperature overnight, then diluted with water, extracted with CH2Cl2 and dried over anhydrous Na2SO4. The crude product was purified using flash column chromatography to give the triazolopyridine 10 (748 mg, 2.23 mmol, 60%) as an off-white solid. 1H NMR (500 MHz, CDCl3) δ 8.03 (t, J = 1.3 Hz, 1H), 7.61 (dd, J = 9.6, 1.0 Hz, 1H), 7.47 (td, J = 7.5, 1.5 Hz, 1H), 7.44–7.39 (m, 3H), 7.37 (t, J = 7.4 Hz, 1H), 2.25 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 148.5, 145.8, 138.7, 135.1, 131.3, 130.8, 130.2, 127.6, 126.4, 125.0, 117.5, 77.7, 19.9; m/z (ESI+) 336.0 ([M + H]+, 100%); HRMS (ESI+) C13H11N3I+ ([M + H]+) requires 335.9992; found 335.9988.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.